Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

ExaStim Upper Limb Home Use Clinical Validation Study

A legfontosabb adatok

Ki végzi
Niche Biomedical, Inc. dba ANEUVO
Hol
Baltimore, Boston, Denver, Downer Grove és Milwaukee (Egyesült Államok)Mind a 5 helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
33 fő vett részt
Kezdés
2025. márc. 17.
Befejezés
2026. márc. 11.
A vizsgálat típusa
Beavatkozással járó
A vizsgált kezelések
  • ExaStim Stimulation System
A regiszteradat frissítve
2026. április 13.

Ki vehet részt

Életkor
22 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Nem vehetnek részt

A regiszter feltételei, szó szerint

Mind a 26 feltétel megnézéseKevesebb

Ki vehet részt

  • Subject must have completed the ASPIRE clinical trial
  • Subject must be ≥ 22 years of age at the time of the screening examination
  • Subject must have a traumatic, chronic* spinal cord injury between C2 and T2 inclusive
  • Subject must have American Spinal Injury Association (ASIA) Impairment Scale A, B, C, or D via the ISNCSCI exam
  • Subject must have limited function of upper extremities with ISNCSCI Upper Extremity Motor Score for each arm from 5 to 20 inclusive
  • Subject must have a non-zero score in least one of the UEMS C7, C8 and T1 muscles on either side
  • Subject must have regular availability of a caregiver and/or family member to assist with donning and doffing the device and to assist with completion of session-related report forms
  • Subject, caregiver, and/or family member must be available for all in-clinic study visits and adhere to the study protocol
  • Subject, caregiver and/or family member must be able to use a digital mobile device, have reliable access to internet, and be able to complete all study related forms and questionnaires
  • Subject and caregiver must be able to commit to participating in a six-week study, be willing to comply with study instructions, agree to make all office and telehealth appointments, engage in a minimum of 12-minutes of home activities with stimulation per week, and complete the entire course of the study
  • Subject must be a primary/fluent English speaker
  • Subject must be able and willing to read, comprehend and give Authorization for Use/Disclosure of Health Information (HIPAA) and informed consent

Ki nem vehet részt

  • Other internal metallic objects of unknown or foreign origin (unidentifiable surgical implants, shrapnel, bullet fragments, etc.)
  • Botox injections to the upper limb in prior 6 months
  • Acute medical conditions under active treatment that would contraindicate standard rehabilitation including open wounds, unhealed bone fractures, peripheral neuropathies or painful musculoskeletal dysfunction
  • Allergy to hydrogel, silicone, latex or other product materials
  • Uncontrolled cardiopulmonary disease
  • Uncontrolled epilepsy or seizures
  • Unmanaged depression, psychiatric disorders or ongoing substance abuse
  • Active implanted medical device for electrical stimulation
  • Uncontrolled autonomic dysreflexia or orthostatic hypotension
  • BMI > 40.0 (morbid obesity)
  • Subjects who are pregnant or planned pregnancy during the study. Note: Subjects of childbearing potential must agree to the use an effective contraceptive for the duration of the study
  • Compromised skin in the area for electrode contact (back of neck and/or hip area)
  • Ventilator dependency
  • Participation in another clinical trial that may interfere with this study

Helyszínek itt: Egyesült Államok

  • Internation Center for Spinal Cord Injury at the Kennedy Krieger InstituteBaltimore, Egyesült Államok
  • Spaulding Rehabilitation HospitalBoston, Egyesült Államok
  • Craig Rehabilitation HospitalDenver, Egyesült Államok
  • TryAbility Neurorecovery CenterDowner Grove, Egyesült Államok
  • Marquette University Neuro Recovery ClinicMilwaukee, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

This is a multi-center, observational, single-arm, 6-week home study to evaluate the safety and efficacy of transcutaneous spinal cord stimulation via the ExaStim system for 4 consecutive weeks used in the home setting for individuals with traumatic spinal cord injury. The study consists of a baseline evaluation and 1-week training period (Week 0), a 4-week stimulation period (Weeks 1-4), and a follow-up visit (Week 5), for a total expected duration of participation for each subject of six weeks.

A vizsgálat csoportja

  • Transcutaneous Spinal Stimulation in the home settingA vizsgált kezelés

    Subjects will perform activities of daily living in conjunction with the ExaStim over a 4-week period in the home setting. In each session, subjects will receive stimulation while performing therapist-prescribed activities of daily living. Stimulation must be utilized for a maximum of 300 -minutes per week and a minimum of 125-minutes per week. The time spent using stimulation during home sessions, and the number of sessions that patients perform each week, is flexible and is intended to facilitate the use of ExaStim within each participant's daily routine.

    Kezelés: ExaStim Stimulation System

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2026. április 13.